<code id='CFCB269E55'></code><style id='CFCB269E55'></style>
    • <acronym id='CFCB269E55'></acronym>
      <center id='CFCB269E55'><center id='CFCB269E55'><tfoot id='CFCB269E55'></tfoot></center><abbr id='CFCB269E55'><dir id='CFCB269E55'><tfoot id='CFCB269E55'></tfoot><noframes id='CFCB269E55'>

    • <optgroup id='CFCB269E55'><strike id='CFCB269E55'><sup id='CFCB269E55'></sup></strike><code id='CFCB269E55'></code></optgroup>
        1. <b id='CFCB269E55'><label id='CFCB269E55'><select id='CFCB269E55'><dt id='CFCB269E55'><span id='CFCB269E55'></span></dt></select></label></b><u id='CFCB269E55'></u>
          <i id='CFCB269E55'><strike id='CFCB269E55'><tt id='CFCB269E55'><pre id='CFCB269E55'></pre></tt></strike></i>

          fashion

          fashion

          author:Wikipedia    Page View:9
          STAT

          What if CRISPR isn’t all that commercial? How does the NurOwn story end? And how do you pronounce “Bayer”?

          We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Live from Boston at the 2023 STAT Summit, we discuss the latest news in the life sciences, including a milestone in genome editing, a twist in the search for ALS treatments, and the polarizing process of saying words in biotech.

          advertisement

          For more on what we cover, here’s the latest from the Summit; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          advertisement

          explore

          Heart attack and stroke risk calculators need revising
          Heart attack and stroke risk calculators need revising

          AdobeForbusyprimarycarephysicianslikeme,anannualphysicalwitha27-year-oldmaleisablessing.Sincewe’real

          read more
          Biogen Alzheimer’s drug launch off to slow start
          Biogen Alzheimer’s drug launch off to slow start

          Illustration:AlexHogan/STAT;Photo:EisaiviaAPSevenmonthsafterUSdrugregulatorsfullyapprovedBiogen’stre

          read more
          Affirmative action in medical school literally saved lives
          Affirmative action in medical school literally saved lives

          AdobeThepastseveralmonthshavebeengrimforhealthintheU.S.InDecember,theCentersforDiseaseControlandPrev

          read more

          What STAT readers think about the FDA and patient advocacy

          MollyFergusonforSTATSTATnowpublishesselectedLetterstotheEditorreceivedinresponsetoFirstOpinionessays